Literature DB >> 30228577

Opioid Use Disorder and Pregnancy.

Frederick T O'Donnell1, Daniel L Jackson2.   

Abstract

Over-prescription of opioid pain medications and increases in heroin use have contributed to the sharp rise in opioid-related hospitalizations and overdose deaths among young adults in the United States, including pregnant women. This has imposed substantial direct and indirect costs to our nation's health care system. Effective treatment with methadone and buprenorphine is available, but significant barriers to care may restrict access for many. Improved screening tools and expanded access to treatments for substance use disorders are keys to addressing the epidemic of opioid use disorder.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 30228577      PMCID: PMC6140233     

Source DB:  PubMed          Journal:  Mo Med        ISSN: 0026-6620


  30 in total

1.  Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"?

Authors:  Susan L Ettner; David Huang; Elizabeth Evans; Danielle Rose Ash; Mary Hardy; Mickel Jourabchi; Yih-Ing Hser
Journal:  Health Serv Res       Date:  2006-02       Impact factor: 3.402

2.  Mandatory use of prescription drug monitoring programs.

Authors:  Rebecca L Haffajee; Anupam B Jena; Scott G Weiner
Journal:  JAMA       Date:  2015-03-03       Impact factor: 56.272

3.  Prevalence of prescription opioid-use disorder among chronic pain patients: comparison of the DSM-5 vs. DSM-4 diagnostic criteria.

Authors:  Joseph A Boscarino; Margaret R Rukstalis; Stuart N Hoffman; John J Han; Porat M Erlich; Stephen Ross; Glenn S Gerhard; Walter F Stewart
Journal:  J Addict Dis       Date:  2011 Jul-Sep

4.  A Moral or Medical Problem? The Relationship between Legal Penalties and Treatment Practices for Opioid Use Disorders in Pregnant Women.

Authors:  Cara Angelotta; Carol J Weiss; John W Angelotta; Richard A Friedman
Journal:  Womens Health Issues       Date:  2016-10-20

5.  Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009.

Authors:  Stephen W Patrick; Robert E Schumacher; Brian D Benneyworth; Elizabeth E Krans; Jennifer M McAllister; Matthew M Davis
Journal:  JAMA       Date:  2012-04-30       Impact factor: 56.272

6.  Using textual cause-of-death data to study drug poisoning deaths.

Authors:  Eric M Ossiander
Journal:  Am J Epidemiol       Date:  2014-02-11       Impact factor: 4.897

7.  Reducing the Risks of Relief--The CDC Opioid-Prescribing Guideline.

Authors:  Thomas R Frieden; Debra Houry
Journal:  N Engl J Med       Date:  2016-03-15       Impact factor: 91.245

8.  Buprenorphine induces ceiling in respiratory depression but not in analgesia.

Authors:  A Dahan; A Yassen; R Romberg; E Sarton; L Teppema; E Olofsen; M Danhof
Journal:  Br J Anaesth       Date:  2006-03-17       Impact factor: 9.166

9.  Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-Related Death Rates.

Authors:  Stephen W Patrick; Carrie E Fry; Timothy F Jones; Melinda B Buntin
Journal:  Health Aff (Millwood)       Date:  2016-06-22       Impact factor: 6.301

10.  Vital Signs: Demographic and Substance Use Trends Among Heroin Users - United States, 2002-2013.

Authors:  Christopher M Jones; Joseph Logan; R Matthew Gladden; Michele K Bohm
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-07-10       Impact factor: 17.586

View more
  2 in total

1.  Estimating the impact on initiating medications for opioid use disorder of state policies expanding Medicaid and prohibiting substance use during pregnancy.

Authors:  Sugy Choi; Michael D Stein; Julia Raifman; David Rosenbloom; Jack A Clark
Journal:  Drug Alcohol Depend       Date:  2021-10-29       Impact factor: 4.492

2.  Motherhood, pregnancy and gateways to intervene in substance use disorder.

Authors:  Sugy Choi; Michael D Stein; Julia Raifman; David Rosenbloom; Jack A Clark
Journal:  Health Soc Care Community       Date:  2021-08-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.